Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jenscare Scientific CoHKSE:09877 -0.20%33 Net Current Asset Value is HK$1.36 as of Dec. 2025, which is 100% below its 10-year median of 7.38. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 569 Medical Devices & Instruments companies, Jenscare Scientific Co ranks worse than 50.97% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Jenscare Scientific Co's net current asset value per share for the quarter that ended in Dec. 2025 was HK$1.36.
The historical rank and industry rank for Jenscare Scientific Co's Net Current Asset Value or its related term are showing as below:
HKSE:09877'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 2.15 Med: 7.38 Max: 31.03
Current: 5.5
During the past 6 years, the highest Price-to-Net-Current-Asset-Value Ratio of Jenscare Scientific Co was 31.03. The lowest was 2.15. And the median was 7.38.
HKSE:09877's Price-to-Net-Current-Asset-Value is ranked worse than 50.97% of 569
companies
in the Medical Devices & Instruments industry
Industry Median: 5.26
vs HKSE:09877: 5.50
Jenscare Scientific Co (HKSE:09877) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Jenscare Scientific Co Net Current Asset Value Related Terms
Jenscare Scientific Co Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Jenscare Scientific Co's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenscare Scientific Co Net Current Asset Value Chart
HKSE:09877 vs ABT, SYK, MDT: Net Current Asset Value Comparison
For the Medical Devices subindustry, Jenscare Scientific Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenscare Scientific Co Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of HK$1.36 mean?
Jenscare Scientific Co (HKSE:09877) has a Net Current Asset Value of HK$1.36 as of Dec. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Jenscare Scientific Co and its competitors. This is 82% below median its historical median of 7.38. Over the past decade, Jenscare Scientific Co's Net Current Asset Value has ranged from 2.15 to 31.03. According to the industry distribution chart, Jenscare Scientific Co ranks #290 out of 569 companies in the Medical Devices & Instruments industry, placing it in the top 51%.
Is Jenscare Scientific Co's Net Current Asset Value too high?
Jenscare Scientific Co's current Net Current Asset Value of HK$1.36 is 82% below median its 10-year median of 7.38. Over the past 10 years, this metric has ranged from a low of 2.15 to a high of 31.03. Based on the distribution chart, Jenscare Scientific Co ranks #290 out of 569 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's Net Current Asset Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Jenscare Scientific Co ranks #290 out of 569 companies for Net Current Asset Value. This places Jenscare Scientific Co in the lower half of its industry. The industry median Net Current Asset Value is 5.26. Historically, Jenscare Scientific Co's own Net Current Asset Value has ranged from 2.15 to 31.03 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.26, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Jenscare Scientific Co and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jenscare Scientific Co's current Net Current Asset Value is HK$1.36, which is 82% below median its own 10-year median of 7.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current Net Current Asset Value of HK$1.36. The current Net Current Asset Value is HK$1.36, which is 82% below median its 10-year median of 7.38. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current Net Current Asset Value is HK$1.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score
Get the complete analysis for HKSE:09877
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09877 has been successfully added to your 
